financetom
Business
financetom
/
Business
/
CoStar Q2 Adjusted Earnings, Revenue Rise; Issues Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CoStar Q2 Adjusted Earnings, Revenue Rise; Issues Guidance
Jul 22, 2025 1:40 PM

04:25 PM EDT, 07/22/2025 (MT Newswires) -- CoStar Group ( CSGP ) reported Q2 adjusted earnings late Tuesday of $0.17 per diluted share, up from $0.15 a year earlier.

Analysts polled by FactSet expected $0.14.

Net sales for the quarter ended June 30 were $781.3 million, up from $677.8 million a year earlier.

Analysts surveyed by FactSet expected $772.2 million.

For Q3, the company expects adjusted EPS of $0.15 to $0.17 on revenue of $800 million to $805 million. Analysts expected EPS of $0.22 on revenue of $803 million in a FactSet poll.

For the full year, it expects adjusted EPS of $0.76 to $0.80 on revenue of $3.14 billion to $3.16 billion. Analysts expected EPS of $0.83 on revenue of $3.14 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Amazon CEO Says Third-Party Sellers Likely to Pass Tariff Costs to Customers
Market Chatter: Amazon CEO Says Third-Party Sellers Likely to Pass Tariff Costs to Customers
Apr 10, 2025
08:54 AM EDT, 04/10/2025 (MT Newswires) -- Amazon.com ( AMZN ) Chief Executive Andy Jassy said Thursday its network of third-party sellers may pass the cost of President Donald Trump's tariffs on to consumers, CNBC reported. Amazon ( AMZN ) did not immediately reply to a request for comment from MT Newswires. (Market Chatter news is derived from conversations with...
Oculis Completes Enrollment in Late-Stage Diabetic Macular Edema Trials
Oculis Completes Enrollment in Late-Stage Diabetic Macular Edema Trials
Apr 10, 2025
08:54 AM EDT, 04/10/2025 (MT Newswires) -- Oculis Holding ( OCS ) said Thursday that it has completed enrollment in two late-stage trials of OCS-01 eye drops in diabetic macular edema. The trials, which enrolled more than 800 patients from the US and other countries, will assess the eye drops' efficacy and safety after 52 weeks of treatment, the company...
US regional banks face results test as tariffs trigger uncertainty, growth worries
US regional banks face results test as tariffs trigger uncertainty, growth worries
Apr 10, 2025
(Reuters) - Heightened uncertainty fueled by the on-and-off U.S. tariffs will likely take center stage as the nation's regional banks gear up to report first-quarter results next week, with investors tracking signs of stress in asset quality. President Donald Trump's decision to pause many of his new reciprocal tariffs for 90 days provided a reprieve to regional bank stocks on...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved